Exploration of the P3 region of PEXEL peptidomimetics leads to a potent inhibitor of the Plasmodium protease, plasmepsin V

被引:10
|
作者
Gazdik, Michelle
Jarman, Kate E.
O'Neill, Matthew T.
Hodder, Anthony N.
Lowes, Kym N.
Sabroux, Helene Jousset
Cowman, Alan F.
Boddey, Justin A.
Sleebs, Brad E. [1 ]
机构
[1] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Plasmepsin V; Peptidomimetics; Arginine isosteres; Malaria; PEXEL; THROMBIN INHIBITORS; ARGININE MIMETICS; HOST ERYTHROCYTE; PROTEINS; MALARIA; ARTEMISININ; EXPORT; FALCIPARUM; VIRULENCE; PEPTIDE;
D O I
10.1016/j.bmc.2016.03.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The use of arginine isosteres is a known strategy to overcome poor membrane permeability commonly associated with peptides or peptidomimetics that possess this highly polar amino acid. Here, we apply this strategy to peptidomimetics that are potent inhibitors of the malarial protease, plasmepsin V, with the aim of enhancing their activity against Plasmodium parasites, and exploring the structure-activity relationship of the P-3 arginine within the S-3 pocket of plasmepsin V. Of the arginine isosteres trialled in the P-3 position, we discovered that canavanine was the ideal and that this peptidomimetic potently inhibits plasmepsin V, efficiently blocks protein export and inhibits parasite growth. Structure studies of the peptidomimetics bound to plasmepsin V provided insight into the structural basis for the enzyme activity observed in vitro and provides further evidence why plasmepsin V is highly sensitive to substrate modification. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1993 / 2010
页数:18
相关论文
共 19 条
  • [1] Structural Rationale for the Recognition of Arginine at P3 in PEXEL Motif Containing Proteins of Plasmodium falciparum by Plasmepsin V
    Guruprasad, Lalitha
    Tanneeru, Karunakar
    Guruprasad, Kunchur
    PROTEIN AND PEPTIDE LETTERS, 2011, 18 (06): : 634 - 641
  • [2] Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P2 position of PEXEL peptidomimetics
    Nguyen, William
    Hodder, Anthony N.
    de Lezongard, Richard Bestel
    Czabotar, Peter E.
    Jarman, Kate E.
    O'Neill, Matthew T.
    Thompson, Jennifer K.
    Sabroux, Helene Jousset
    Cowman, Alan F.
    Boddey, Justin A.
    Sleebs, Brad E.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 154 : 182 - 198
  • [3] Transition State Mimetics of the Plasmodium Export Element Are Potent Inhibitors of Plasmepsin V from P-falciparum and P-vivax
    Sleebs, Brad E.
    Gazdik, Michelle
    O'Neill, Matthew T.
    Rajasekaran, Pravin
    Lopaticki, Sash
    Lackovic, Kurt
    Lowes, Kym
    Smith, Brian J.
    Cowman, Alan F.
    Boddey, Justin A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (18) : 7644 - 7662
  • [4] Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands
    Chen, XQ
    Kempf, DJ
    Sham, HL
    Green, BE
    Molla, A
    Korneyeva, M
    Vasavanonda, S
    Wideburg, NE
    Saldivar, A
    Marsh, KC
    McDonald, E
    Norbeck, DW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (24) : 3531 - 3536
  • [5] Synthesis, antiviral activity, and conformational studies of a P3 aza-peptide analog of a potent macrocyclic tripeptide HCV protease inhibitor
    Randolph, John T.
    Zhang, Xiaolin
    Huang, Peggy P.
    Klein, Larry L.
    Kurtz, Kevin A.
    Konstantinidis, Alex K.
    He, Wenping
    Kati, Warren M.
    Kempf, Dale J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (08) : 2745 - 2750
  • [6] A Concise Synthesis of the HCV Protease Inhibitor BILN 2061 and Its P3 Modified Analogs
    Liu Dejun
    Dong Jingchao
    Yin Yunxing
    Ma Rujian
    Shi Yifeng
    Wu Hao
    Chen Shuhui
    Li Ge
    CHINESE JOURNAL OF CHEMISTRY, 2011, 29 (07) : 1489 - 1502
  • [7] C-terminal hydrophobic region leads PRSV P3 protein to endoplasmic reticulum
    Eiamtanasate S.
    Juricek M.
    Yap Y.-K.
    Virus Genes, 2007, 35 (3) : 611 - 617
  • [8] Novel potent inhibitors of hepatitis C virus (HCV) NS3 protease with cyclic sulfonyl P3 cappings
    Chen, Kevin X.
    Vibulbhan, Bancha
    Yang, Weiying
    Nair, Latha G.
    Tong, Xiao
    Cheng, Kuo-Chi
    Njoroge, F. George
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (04) : 1105 - 1109
  • [9] Erratum to: C-terminal hydrophobic region leads PRSV P3 protein to endoplasmic reticulum
    Sarasate Eiamtanasate
    Mila Juricek
    Yun-Kiam Yap
    Virus Genes, 2007, 35 : 875 - 876
  • [10] A new synthesis of peptidyl epoxysuccinates for probing cysteine protease-inhibitor P3/S3 binding interactions
    Roush, WR
    Hernandez, AA
    Zepeda, G
    SYNTHESIS-STUTTGART, 1999, : 1500 - 1504